Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

About 42 million Medicaid patients do not have the guaranteed ability to participate in clinical trials.
Dr. Linus T. Chuang outlines challenges and opportunities for global cancer care on World Cancer Research Day.
A recent study on the risk of Alzheimer's disease or dementia following the use of ADT was disturbing to me on two levels.
Does big data have a big problem? Dr. John W. Sweetenham cautions, "There is a real danger that we legitimize flawed data sets by labelling them as 'real-world data' when they neither reflect the real world nor can we trust the data."
As a physician and future pediatric oncologist, Dr. Rachel Offenbacher believes that providers have the responsibility to be vocal about the critical importance of vaccines.
"We believe what mattered the most about #ASCO19 is that patients were part of the discussion," write Dr. Mark A. Lewis and Dr. Chadi Nabhan.
Social media is a largely untapped resource for researchers to utilize for the purpose of successfully completing trials.
Dr. Sharpless joined me to talk about pediatric cancer research, clinical trial methodology, eligibility criteria, and more.
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as well as controlling the next generation of tobacco products.
A recent study should serve as a wake-up call to all Americans that obesity is linked to an increased risk of common cancers.
ASCO’s Clinical Cancer Advances report, our 14th edition, examines the most transformative research of the past year and offers our vision for future research priorities.
Predictive analytics, complex treatment pathways, tele-oncology, and more: Dr. Robert M. Daly identifies five trends that are poised to disrupt oncology practice in the coming year.
Social injustice is perpetuated when patients can't afford to participate in essential clinical research.
GLOBOCAN 2018 indicates a significant global increase in the numbers, incidence, and mortality rates, albeit significant differences in mortality amongst countries of different economic levels. 
ASCO's nearly 45,000 members practice in more than 150 countries, and continued progress against cancer will require every one of us, writes ASCO CMO Dr. Richard L. Schilsky.
Broadening eligibility critera for cancer clinical trials will give more patients the opportunity to contribute to scientific research.
ASCO CMO Dr. Richard L. Schilsky invites all cancer researchers to come together for education and networking around cancer clinical trials.
Dr. Arjun Gupta reconsidered an order (and the evidence) for a neutropenic diet when it negatively affected his patient's quality of life.  

Pages


Advertisement